Nom du produit:3,9-dibromo-5H,6H,8H,9H-[1,2,4]triazolo[4,3-d][1,4]oxazepine

IUPAC Name:3,9-dibromo-5H,6H,8H,9H-[1,2,4]triazolo[4,3-d][1,4]oxazepine

CAS:2060053-25-8
Formule moléculaire:C6H7Br2N3O
Pureté:95%+
Numéro de catalogue:CM428401
Poids moléculaire:296.95

Unité d'emballage Stock disponible Prix($) Quantité
CM428401-10mg 3-4 Weeks ƥŗȃ
CM428401-50mg 3-4 Weeks Źŗǵ
CM428401-100mg 4-5 Weeks ƓŗǤ
CM428401-250mg 4-5 Weeks ǵʼnǵ
CM428401-500mg 5-6 Weeks ȃŹIJIJ
CM428401-1g 5-6 Weeks ȃǤǵǤ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2060053-25-8
Formule moléculaire:C6H7Br2N3O
Point de fusion:-
Code SMILES:BrC1COCCN2C(Br)=NN=C12
Densité:
Numéro de catalogue:CM428401
Poids moléculaire:296.95
Point d'ébullition:
N° Mdl:MFCD30497951
Stockage:

Category Infos

Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.

Related Products